Caliper, Pfizer to Explore New Therapeutic Indications for Drugs in the Pipeline

In the future, perhaps any and all new indications for drugs will be discovered and brought forth before approval.  Moving in this direction is a new project involving Pfizer and Caliper, which will perform in-vivo tests evaluating new indications for drugs in Pfizer’s pipeline.  For more, here is the press release.